Seres Therapeutics's market cap is currently $145.48M. The company's EPS TTM is €-1.9213515398999998; its P/E ratio is ―; Seres Therapeutics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is €0.39. See an overview of income statement, balance sheet, and cash flow financials.
